Cargando…

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine

Detalles Bibliográficos
Autor principal: Zeng, Guangting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154357/
https://www.ncbi.nlm.nih.gov/pubmed/35659883
http://dx.doi.org/10.1016/S2666-5247(22)00150-1
_version_ 1784718019845423104
author Zeng, Guangting
author_facet Zeng, Guangting
author_sort Zeng, Guangting
collection PubMed
description
format Online
Article
Text
id pubmed-9154357
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-91543572022-06-02 Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine Zeng, Guangting Lancet Microbe Correspondence The Author(s). Published by Elsevier Ltd. 2022-08 2022-05-31 /pmc/articles/PMC9154357/ /pubmed/35659883 http://dx.doi.org/10.1016/S2666-5247(22)00150-1 Text en © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Zeng, Guangting
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
title Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
title_full Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
title_fullStr Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
title_full_unstemmed Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
title_short Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
title_sort safety and immunogenicity of the sars-cov-2 arcov mrna vaccine
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154357/
https://www.ncbi.nlm.nih.gov/pubmed/35659883
http://dx.doi.org/10.1016/S2666-5247(22)00150-1
work_keys_str_mv AT zengguangting safetyandimmunogenicityofthesarscov2arcovmrnavaccine